Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc. | 8 | 0 | 3 | 0 | €1.55 | €9.13 | 488.241% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.72 | €8.52 | 80.585% |
| Affimed N.V. | 11 | 6 | 0 | 0 | €0.55 | €7.92 | 1331.338% |
| Inogen Inc. | 1 | 2 | 0 | 0 | €11.40 | €6.53 | -42.680% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 0 | €3.67 | €6.45 | 75.820% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €3.00 | €5.55 | 85.120% |
| Geron Corp. | 15 | 0 | 1 | 0 | €4.06 | €5.52 | 35.978% |
| Chimerix Inc. | 4 | 1 | 3 | 0 | €0.85 | €5.46 | 542.000% |
| Savara Inc. | 1 | 0 | 0 | 0 | €3.80 | €5.00 | 31.579% |
| Heron Therapeutics Inc. | 11 | 1 | 1 | 0 | €1.78 | €4.63 | 160.022% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €2.53 | €4.62 | 82.668% |
| Akebia Therapeutics Inc. | 5 | 2 | 0 | 0 | €1.40 | €4.12 | 194.793% |
| Compugen Ltd. | 3 | 2 | 0 | 0 | €1.83 | €3.66 | 99.815% |
| Sangamo Therapeutics Inc. | 11 | 15 | 1 | 0 | €0.76 | €3.64 | 377.350% |
| Cerus Corp. | 4 | 0 | 0 | 0 | €2.04 | €3.26 | 59.623% |
| Cytosorbents Corp. | 3 | 0 | 0 | 0 | €0.91 | €3.25 | 256.568% |
| Pulmatrix Inc. | 1 | 1 | 0 | 0 | €1.76 | €3.00 | 70.455% |
| Rockwell Medical Inc. | 1 | 0 | 0 | 0 | €2.61 | €3.00 | 14.767% |
| ProQR Therapeutics N.V. | 7 | 2 | 0 | 0 | €1.85 | €2.32 | 25.720% |
| Adaptimmune Therapeutics PLC ADR | 1 | 0 | 0 | 0 | €1.15 | €2.00 | 73.913% |
| Brainstorm Cell | 2 | 0 | 0 | 0 | €0.28 | €1.84 | 554.902% |
| Stratec SE | 3 | 0 | 1 | 0 | €43.85 | €0.000 | -100.000% |
| Immunogen Inc. | 2 | 0 | 0 | 0 | €28.97 | - | - |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €94.64 | - | - |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €23.20 | - | - |